Abreos Biosciences Overview
- Founded
- 2013

- Status
- Acquired/Merged
- Employees
- 6

- Latest Deal Type
- M&A
Abreos Biosciences General Information
Description
Developer of peptide antigen mimetics technology designed to improve the development and commercialization of biopharmaceuticals. The company's platform are laboratory-based and point-of-care assays that enable precision dosing and counterfeit detection of biologic drugs as well as permits for direct monitoring of blood concentrations of monoclonal antibody drugs for dosage, enabling health care industry to get customizable assay to improve outcome.
Contact Information
(Operating Subsidiary)
- 2223 Avenida de la Playa
- Suite 206
- La Jolla, CA 92037
- United States
Abreos Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 25-Jan-2021 | 00.000 | Completed | Generating Revenue | ||
7. Seed Round | 15-Sep-2020 | 00.000 | 00.000 | Completed | Generating Revenue | |
6. Grant | 25-Feb-2020 | 00.000 | 00.000 | Completed | Generating Revenue | |
5. Seed Round | 29-Mar-2016 | 000 | Cancelled | Generating Revenue | ||
4. Seed Round | 28-Jun-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
3. Grant | 25-Sep-2015 | 00.000 | Completed | Generating Revenue | ||
2. Grant | 23-Sep-2014 | $371K | Completed | Generating Revenue | ||
1. Accelerator/Incubator | 01-Jan-2014 | Completed | Generating Revenue |
Abreos Biosciences Comparisons
Industry
0000000
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAbreos Biosciences Competitors (15)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Trianni | Formerly Accelerator/Incubator backed | San Francisco, CA | 0 | 000000&0 | ||
00000 0000000 0000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 00000000 | |
00000000000 | Private Debt Financed | Rosemont, IL | 000 | 000000000 - | ||
000000 00000000000 | Formerly VC-backed | Burlingame, CA | 00 | 00000 | 000000 - 000 | 00000 |
Abreos Biosciences Patents
Abreos Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180291059-A1 | Immunoaffinity purification of antibodies using mimetopes | Abandoned | 04-Apr-2017 | 00000000 | |
EP-3606937-A4 | Immunoaffinity purification of antibodies using mimetopes | Withdrawn | 04-Apr-2017 | 00000000 | |
EP-3606937-A1 | Immunoaffinity purification of antibodies using mimetopes | Withdrawn | 04-Apr-2017 | 00000000 | |
EP-3497444-A4 | Detection and quantification of natalizumab | Pending | 12-Aug-2016 | 00000000000 | 0 |
EP-3497444-A1 | Detection and quantification of natalizumab | Pending | 12-Aug-2016 | G01N33/6854 |
Abreos Biosciences Executive Team (8)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bradley Messmer Ph.D | Co-Founder, Chief Executive Officer, President & Board Member | ||
Reed McCalmon | Director of Finance | ||
Michael Williams | Board Advisor |
Abreos Biosciences Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Bradley Messmer Ph.D | Abreos Biosciences | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |
Neil Senturia | Blackbird Ventures (La Jolla) | Executive Chairman & Advisor | 000 0000 |
Abreos Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAbreos Biosciences Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Blackbird Ventures (La Jolla) | Venture Capital | Minority | 000 0000 | 000000 0 | |
CONNECT (Accelerator) | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
Keshif Ventures | Angel Group | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
TLP | Asset Manager | Minority | 000 0000 | 000000 0 |
Abreos Biosciences Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 | 27-Nov-2019 | 00000 0000 | Monitoring Equipment |